ID 200267549 · FY 2017–2024 · 8 years
GNG Pharma (ჯიენჯი ფარმა, gng.ge) — a Tbilisi retail pharmacy offering medicines, health supplements and personal-care products with home delivery (e.g. via Glovo). Retail-level margins (~30%); active and growing (revenue ~GEL 2.4m in 2017 to ~GEL 6–7m).
curated 2026-06-25
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,420 | 3,622 | 4,767 | 6,282 | 6,152 | 7,443 | 6,737 | 6,249 | +14.5% |
| Total COGS | -2,119 | -2,701 | -3,462 | -4,380 | -4,116 | -4,951 | -4,366 | -4,011 | +9.5% |
| Gross Profit | 301 | 921 | 1,305 | 1,902 | 2,037 | 2,492 | 2,371 | 2,238 | +33.2% |
| Gross Margin | 12.4% | 25.4% | 27.4% | 30.3% | 33.1% | 33.5% | 35.2% | 35.8% | |
| Total Operating Expenses | 0 | -783 | -1,324 | -1,698 | -2,049 | -2,588 | -2,523 | -2,026 | +17.2% |
| EBITDA | 301 | 138 | -18 | 204 | -12 | -95 | -152 | 211 | -4.9% |
| EBITDA Margin | 12.4% | 3.8% | -0.4% | 3.3% | -0.2% | -1.3% | -2.3% | 3.4% | |
| Total D&A | 0 | -30 | -41 | -49 | -53 | -55 | -44 | -46 | +7.5% |
| EBIT / Operating Income | 301 | 108 | -59 | 156 | -65 | -150 | -196 | 165 | -8.2% |
| Total Other Income | 0 | 0 | 0 | 132 | 111 | 0 | 0 | -159 | nmf |
| Profit Before Tax | 301 | 108 | -59 | 287 | 46 | -150 | -196 | 6 | -42.2% |
| Total Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -25 | |
| Net Profit / (Loss) | 4,538 | 138 | -18 | 204 | -12 | -95 | -152 | 28 | nmf |
| Net Margin | 187.6% | 3.8% | -0.4% | 3.3% | -0.2% | -1.3% | -2.3% | 0.5% |
Ownership & directors from companyinfo.ge (public corporate registry).